APA (7th ed.) Citation

Wang, L., Yang, W., Wang, Y., Niu, T., Fu, R., Zhong, Y., . . . Lu, J. (2025). Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-13925-3

Chicago Style (17th ed.) Citation

Wang, Luqun, et al. "Real-world Analysis of Treatment Patterns, Effectiveness, and Safety of Daratumumab-based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/refractory Multiple Myeloma." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-13925-3.

MLA (9th ed.) Citation

Wang, Luqun, et al. "Real-world Analysis of Treatment Patterns, Effectiveness, and Safety of Daratumumab-based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/refractory Multiple Myeloma." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-13925-3.